While its significance is currently unknown, we note the nexus between EGFR inhibition and androgen activity [19], that anti-estrogens are used combined with Gefitinib against breast and lung cancers [20], whereas corticosteroids are used to treat side-effects of Gefitinib [21]. This evidence concerns the gene EGFR and lung carcinoma.